These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. The effect of methotrexate on spontaneous mammary adenocarcinomata in female C3H mice. Shewell J Br J Cancer; 1976 Feb; 33(2):210-6. PubMed ID: 1083245 [TBL] [Abstract][Full Text] [Related]
28. Host immune potentiation of drug responses to a murine mammary adenocarcinoma. Radov LA; Haskill JS; Korn JH Int J Cancer; 1976 Jun; 17(6):773-9. PubMed ID: 947856 [No Abstract] [Full Text] [Related]
29. Pre-, peri-, and postoperative chemotherapy for breast cancer: is one better than the other? Murthy MS; Scanlon EF; Reid SE; Yang XF J Surg Oncol; 1996 Apr; 61(4):273-7. PubMed ID: 8627997 [TBL] [Abstract][Full Text] [Related]
30. Treatment of experimental mammary adenocarcinoma with herbicides. Bradley RL; Shoemaker JP; Hoffman RV Cancer Chemother Rep; 1974; 58(5 Pt 1):745-8. PubMed ID: 4138968 [No Abstract] [Full Text] [Related]
31. The effect of chemotherapy on occult metastases after surgical removal of a non-immunogenic mouse carcinoma. Zebro T; Wright EA J Cancer Res Clin Oncol; 1980; 98(3):277-86. PubMed ID: 7228880 [TBL] [Abstract][Full Text] [Related]
32. Failure of short-term treatment with flurbiprofen to enhance the therapeutic effect of cyclophosphamide against rodent sarcomas and a leukaemia. Heckford SE; Eccles SA; Powles TJ; Alexander P Br J Cancer; 1982 Jul; 46(1):51-7. PubMed ID: 7104197 [TBL] [Abstract][Full Text] [Related]
33. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer. Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346 [TBL] [Abstract][Full Text] [Related]
34. Steroid carriers of cytotoxic agents: evaluation of antineoplastic effects of drugs and animal models [proceedings]. Hall TC Cancer Treat Rep; 1978 Aug; 62(8):1263-4. PubMed ID: 688268 [No Abstract] [Full Text] [Related]
35. Flurbiprofen is as effective as naproxen in juvenile spondylitis. Leak AM; Richter MR; St Cyr CH; Ansell BM J Rheumatol; 1986 Jun; 13(3):664-5. PubMed ID: 3735300 [No Abstract] [Full Text] [Related]
36. Control of acute and chronic pain with Ansaid (flurbiprofen). Am J Med; 1986 Mar; 80(3A):1-157. PubMed ID: 3963012 [No Abstract] [Full Text] [Related]
37. Study of the gastric mucosa in rheumatic patients before and after the administration of flurbiprofen. Teixeira AV; Poças L; Serrão D Br J Clin Pract; 1981 Jun; 35(6):222-7. PubMed ID: 7306458 [No Abstract] [Full Text] [Related]
38. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216 [3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]. Wallace JL; Muscará MN; de Nucci G; Zamuner S; Cirino G; del Soldato P; Ongini E J Pharmacol Exp Ther; 2004 May; 309(2):626-33. PubMed ID: 14755007 [TBL] [Abstract][Full Text] [Related]
39. Acute in vivo resistance in high-dose therapy. Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940 [TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with a molecule with anti-inflammatory action: flurbiprofen]. Berti L; Gerli P; Burdo N Clin Ter; 1982 Apr; 101(1):65-9. PubMed ID: 7083793 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]